Toxoplasma gondii, a significant public health risk, is able to infect almost all warm-blooded
animals including humans, and it results in economic losses in production animals. In the …

Several approaches have been used to improve the immunogenicity of DNA vaccines. In the
current study, we constructed the plasmid encoding T. gondii dense granule 14 (GRA14) …

Toxoplasma gondii is an obligate intracellular parasitic protozoan that infects a wide variety
of vertebrates as intermediate hosts. The aim of the current systematic review study is to …

Toxoplasma gondii can cause severe and even fatal disease in human beings and animals.
Effective vaccines may contribute to control toxoplasmosis. GRA 14, a novel secreted dense …

Background With cancer cases escalation, an urgent request to develop novel combating
strategies arise. Pathogen-based cancer-immunotherapy is getting more consideration …

Efficacy of alginate nanoparticles (Alg-NPs) as vaccine delivery for the excretory-secretory
antigens (ESAs) against the virulent strain of Toxoplasma gondii was evaluated. Swiss …

The host resistance against Toxoplasma gondii (T. gondii) infection is related to the initiation
of the immune response. The study aimed to investigate the role of the leucine-rich repeat …

Excretory–secretory antigens (ESAs) of Toxoplasma gondii are one of the candidates for
immunization against toxoplasmosis. For evaluation of immunization, we determined the …

Abstract Background Malaria in Peru is concentrated in the Amazon region, especially in
Loreto, and transmission is focused in rural and peri-urban communities. The government …

La toxoplasmosis es una enfermedad endémica con prevalencia mundial variable, cuyo
agente causal es el parásito Toxoplasma gondii. Para un diagnóstico certero de la infección …